Stifel Financial Corp raised its stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 14.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 106,313 shares of the company's stock after buying an additional 13,239 shares during the period. Stifel Financial Corp's holdings in Ryan Specialty were worth $6,821,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in RYAN. Rakuten Securities Inc. bought a new stake in Ryan Specialty in the fourth quarter valued at approximately $27,000. Principal Securities Inc. boosted its stake in shares of Ryan Specialty by 164.7% in the 4th quarter. Principal Securities Inc. now owns 667 shares of the company's stock valued at $43,000 after purchasing an additional 415 shares during the last quarter. Mizuho Bank Ltd. acquired a new stake in shares of Ryan Specialty during the fourth quarter worth $49,000. Headlands Technologies LLC increased its position in shares of Ryan Specialty by 2,644.8% during the fourth quarter. Headlands Technologies LLC now owns 796 shares of the company's stock worth $51,000 after buying an additional 767 shares during the period. Finally, Harvest Fund Management Co. Ltd bought a new position in Ryan Specialty during the fourth quarter worth $54,000. Institutional investors and hedge funds own 84.82% of the company's stock.
Insider Buying and Selling
In other Ryan Specialty news, EVP Brendan Martin Mulshine sold 30,000 shares of the business's stock in a transaction on Friday, March 14th. The stock was sold at an average price of $69.30, for a total value of $2,079,000.00. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 11.10% of the stock is owned by corporate insiders.
Ryan Specialty Stock Up 3.4 %
RYAN stock traded up $2.21 during mid-day trading on Friday, reaching $67.02. 1,550,883 shares of the company traded hands, compared to its average volume of 967,467. The stock has a market cap of $17.55 billion, a price-to-earnings ratio of 97.13, a P/E/G ratio of 1.19 and a beta of 0.66. Ryan Specialty Holdings, Inc. has a fifty-two week low of $50.15 and a fifty-two week high of $77.16. The firm's 50 day moving average price is $70.17 and its 200 day moving average price is $68.72. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40.
Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its earnings results on Thursday, May 1st. The company reported $0.39 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.39. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The company had revenue of $690.17 million for the quarter, compared to analysts' expectations of $680.80 million. During the same quarter in the previous year, the firm earned $0.35 earnings per share. Ryan Specialty's quarterly revenue was up 25.0% on a year-over-year basis. As a group, equities research analysts predict that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current fiscal year.
Ryan Specialty Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, May 27th. Investors of record on Tuesday, May 13th will be given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.72%. The ex-dividend date is Tuesday, May 13th. Ryan Specialty's payout ratio is currently 69.57%.
Analysts Set New Price Targets
RYAN has been the subject of a number of recent analyst reports. Barclays decreased their price target on Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating for the company in a report on Friday, April 11th. Royal Bank of Canada decreased their target price on Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating for the company in a research note on Friday, February 21st. UBS Group boosted their price target on Ryan Specialty from $82.00 to $84.00 and gave the company a "buy" rating in a research note on Wednesday, February 26th. Wells Fargo & Company reduced their price objective on shares of Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating for the company in a research report on Thursday, April 10th. Finally, TD Cowen assumed coverage on shares of Ryan Specialty in a research note on Thursday, April 10th. They set a "buy" rating and a $89.00 target price on the stock. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, Ryan Specialty has an average rating of "Hold" and a consensus price target of $75.67.
Check Out Our Latest Stock Analysis on Ryan Specialty
Ryan Specialty Profile
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Read More

Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.